Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pharma Tech Industries Names Darrin Schellin CEO | Contract Pharma
Breaking News, Promotions & Moves

Pharma Tech Industries Names Darrin Schellin CEO

Schellin brings more than 20 years of experience in the healthcare and pharmaceutical sectors.

Pharma Tech Industries, a global provider of contract manufacturing and packaging services for pharmaceutical, medical device, and wellness products, has appointed Darrin T. Schellin as the company’s new Chief Executive Officer. 
 
With over 20 years of experience in the healthcare and pharmaceutical sectors, Schellin brings a track record of driving operational excellence and fostering innovation. His leadership will guide Pharma Tech Industries through the next growth phase as the company continues to expand its service offerings and geographic reach.
 
“We are thrilled to welcome Darrin to Pharma Tech Industries,” said Tee Noland, Chairman of the Board. “His deep understanding of the industry, strategic vision, and operational expertise make him the ideal leader to steer our company into the future.”
 
Schellin has held various executive leadership roles throughout his career, most recently serving as Chief Executive Officer at GBI Bio. During his tenure, he was instrumental in transforming the organization from a clinical phase CDMO to a full-service clinical and commercial biotech CDMO, underscoring his ability to drive growth and build strong partnerships within the industry. His experience aligns ideally with Pharma Tech Industries’ long-term goals.
 
“I am honored to join Pharma Tech Industries at such an exciting time in its journey,” said Schellin. “As I step into this leadership role, I’m inspired by the potential we have to innovate and collaborate in driving advancements that will improve lives.  I look forward to working with our talented team to build on the company’s impressive legacy of innovation, quality, and customer focus. Together, we will continue to deliver best-in-class solutions to our partners and customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters